Colorectal cancer is the second most common malignancy diagnosed in Canada. Despite
declining incidence and mortality rates in recent years, there is still a significant number of …

Simple Summary Metastatic colorectal cancer (mCRC) accounts for relevant cancer-related
morbidity and mortality. Novel investigations have reshaped the molecular makeup of …

The medical treatment of metastatic colorectal cancer (mCRC) has advanced significantly
over the last 10 years as the result of the introduction of several active cytotoxic and biologic …

Over the past decade treatment for metastatic colorectal cancer (mCRC) has advanced
beyond single-agent fluoropyrimidine use to include various cytotoxic combination regimens …

In the USA, colorectal cancer is the fourth most prevalent cancer and is the second leading
cause of cancer death after lung cancer. In 2006, 148,610 colorectal cancer cases are …

Colorectal cancer remains one of the most common causes of cancer death in the US, with
approximately a quarter of patients presenting with metastatic disease at the time of …

Colorectal cancer remains one of the major causes of cancer death worldwide. During the
past years, the development of new effective treatment options has led to a considerable …

Metastatic colorectal cancer is a significant cause of morbidity and mortality in the US and
around the world. While several novel cytotoxic and biologic therapies have been …

Introduction: Since late 1990's therapy of metastatic colorectal cancer (mCRC) patients has
changed considerable, and the combination of doublet or triplet chemotherapy and a …

Colorectal cancer (CRC) is the third most common malignancy and the second most
common cause of cancer-related death in the USA. Prognosis is best when the disease is …